Medicxi Ventures Management (Jersey) LTD Centessa Pharmaceuticals PLC Transaction History
Medicxi Ventures Management (Jersey) LTD
- $455 Million
- Q4 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 19,963,157 shares of CNTA stock, worth $332 Million. This represents 73.44% of its overall portfolio holdings.
Number of Shares
19,963,157
Previous 19,963,157
-0.0%
Holding current value
$332 Million
Previous $319 Million
4.75%
% of portfolio
73.44%
Previous 66.33%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$166 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$161 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$106 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$96.5 Million9.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.36MShares$89.2 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.57B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...